NASDAQ:CBIO - Catalyst Biosciences, Inc.
$8.70
 $-0.02
-0.23%
4:00PM EDT
2019-04-18
Catalyst Biosciences, Inc., formerly Targacept, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on creating and developing medicines to address serious medical conditions. The Company focuses its product development efforts in the fields of hemostasis, including the treatment of hemophilia and surgical bleeding, and inflammation, including prevention of delayed graft function (DGF) in renal transplants and the treatment of dry age-related macular degeneration (dry AMD), a condition that can cause visual impairment or blindness. The Company's advanced program is a coagulation Factor VIIa variant, CB 813d, that has completed a Phase I clinical trial in severe hemophilia A and B patients. In addition to its lead Factor VIIa program, it has approximately two other coagulation factors, a Factor IX variant, CB 2679d/ISU 304, that is in advanced preclinical development, and a Factor Xa variant that has reached the advanced lead preclinical-stage of development. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CBIO     avg for
industry  
  avg for
sector  
42 stocks weight:  21. 32   203. 85   241. 91  
42 stocks rank:  2. 78 K 1. 44 K 1. 05 K
# analyst opinions:  3. 00   14. 51   13. 97  
mean recommendation:  1. 70   2. 09   2. 01  

quick ratio:  25. 02   5. 27   1. 81  
current ratio:  25. 83   5. 62   2. 25  

ex-dividend date:     2015-08-19
target price low:  24. 00   84. 80   115. 21  
target price avg:  9. 44   111. 51   137. 51  
target price high:  11. 14   135. 81   157. 84  
1-yr high:  28. 88   114. 23   138. 78  
last close:  8. 70   87. 66   116. 69  
50-day avg:  8. 86   95. 54   123. 44  
200-day avg:  9. 64   94. 25   121. 11  
1-yr low:  6. 59   72. 78   98. 34  
volume:  118. 43 K 4. 11 M 8. 07 M
50-day avg volume:  202. 37 K 2. 76 M 5. 02 M
200-day avg volume:  274. 17 K 2. 92 M 4. 59 M

1-day return:  -0. 23 % -0. 41 % 0. 07 %
this week return:  -7. 15 % -5. 74 % -4. 11 %
12-wk return:  13. 43 % 1. 61 % -0. 05 %
52-wk return:  -67. 63 % 3. 12 % 8. 78 %

enterprise value (EV):  -15. 99 M 48. 94 B 114. 64 B
market cap:  104. 14 M 43. 07 B 104. 73 B
EBITDA:  -33. 57 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  0. 48   4. 22   12. 73  
enterprise/revenue (EV/R):  -2. 66 K 63. 17   12. 84  
total revenue:  6. 00 K 10. 62 B 38. 47 B
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -30. 05 M 2. 20 B 4. 20 B

shares outstanding:  11. 97 M 571. 70 M 1. 24 B
shares:  9. 49 M 571. 81 M 1. 23 B
shares short:  1. 14 M 10. 17 M 13. 00 M
shares short prior month:  1. 00 M 9. 54 M 17. 33 M
short ratio:  6. 21   5. 41   3. 28  
short % of float:  9. 71 % 5. 45 % 2. 38 %
total cash/share:  10. 04   11. 14   9. 33  
total cash:  120. 13 M 6. 71 B 7. 15 B
free cash flow:  -14. 75 M 3. 58 B 2. 96 B
operating cash flow:  -28. 55 M 4. 15 B 4. 30 B

book value:  10. 03   12. 78   26. 92  
price/book:  0. 87   3. 06   -1. 74  
gross profits:  -21. 47 M 8. 04 B 34. 86 B
operating margins:  -562033. 30 % -725. 35 % -89. 04 %
EBITDA margins:  0. 00 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  0. 00 % 37. 08 % 55. 70 %

1-yr max volatility:  -63. 92 % --- ---
1-yr mean volatility:  -0. 23 % 0. 03 % 0. 04 %

1-yr EPS:  -2. 68   2. 40   4. 10  
forward EPS:  -3. 54   3. 97   7. 13  
P/E:  -3. 25   13. 63   22. 72  
forward P/E:  -2. 46   -15. 95   13. 99  
PE/G:  0. 03   -1. 65   -1. 32  
growth:  -100. 00 % 127. 12 % 29. 61 %
earnings high:  -1. 05   1. 00   1. 66  
earnings avg:  -1. 07   0. 77   1. 53  
earnings low:  -1. 10   0. 50   1. 39  
revenue high:  -0. 00   2. 68 B 10. 78 B
revenue avg:  -0. 00   2. 59 B 10. 57 B
revenue low:  -0. 00   2. 49 B 10. 36 B
return on assets:  -25. 64 % -2. 75 % 4. 55 %
return on equity:  -39. 88 % -18. 45 % 5. 46 %
revenue growth:  -100. 00 % 92. 86 % 18. 96 %
revenue/share:  0. 00   13. 29   55. 46  

beta (1yr vs S&P500):  1. 58   1. 25   0. 93  
sharpe (1yr):  -0. 65   0. 37   0. 70  

held % insiders:  7. 05 % 6. 39 % 3. 38 %
held % institutions:  72. 91 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : CBIO
.     + 0.27 =          0.27 :: INITIAL WEIGHT
.   + 51.131 =        51.401 :: inverse volume-to-price addition
.   + 44.077 =        95.477 :: spline projection addition
.    x 4.581 =       437.337 :: 13 weeks' performance factor
.    x 0.572 =       250.199 :: one-year gains+dividend factor
.    x 1.431 =       358.141 :: industry recommendation factor
.    x 2.373 =       849.745 :: symbol recommendation factor
.    x 0.997 =       847.567 :: return on assets factor
.    x 0.996 =       844.186 :: return on equity factor
.     x 0.99 =       835.745 :: revenue growth factor
.     x 4.38 =      3660.976 :: current ratio factor
.    x 1.021 =      3736.397 :: quick ratio factor
.    x 1.078 =       4026.01 :: short ratio factor
.    x 2.009 =      8086.931 :: price-to-book factor
.    x 1.055 =      8531.113 :: EBITDA multiple vs industry factor
.    x 5.618 =     47931.343 :: EBITDA multiple factor
.    x 1.007 =     48290.493 :: 5-day avg > 50-day avg
.     x 2.12 =    102392.831 :: P/E weight
.    x 2.209 =    226181.577 :: PE/G factor
.    x 1.359 =    307382.456 :: beta factor
.    x 0.653 =    200852.758 :: sharpe factor
.     x 2.55 =    512208.511 :: target low factor
.    x 1.097 =    562145.995 :: target mean factor
.    x 1.053 =    591921.539 :: target high factor
.     x 1.31 =    775350.861 :: industry 2-weeks return factor
.    x 0.926 =    718271.227 :: "drift" penalty 2 days ago
.      x 1.0 =    717981.565 :: overall "drift" factor
.    x 0.997 =    716053.247 :: largest single-day jump factor
.    x 0.118 =      84440.24 :: low price factor
.      x 1.0 =     84426.533 :: factor hist industry gain for week 16
.   cubeRoot =        43.869 :: reduced to standardize
.   - 22.548 =        21.321 :: add/subtract for performance
.                     21.321 :: FINAL WEIGHT for NASDAQ:CBIO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org